Table 3.

Mixed-cell complement lysis: simulation study

Study RBC populationSensitization*6% albumin IgMAnti-human IgGComplement-mediated lysisAnti-human C3b/d
20% AET-treated Group O plasma 2+s Weak hemolysis 
 Pooled AB plasma No hemolysis 
PNH sample (9%) Anti-I 1+ 2+ Hemolysis 1+ 
 Pooled AB plasma No hemolysis 
Study RBC populationSensitization*6% albumin IgMAnti-human IgGComplement-mediated lysisAnti-human C3b/d
20% AET-treated Group O plasma 2+s Weak hemolysis 
 Pooled AB plasma No hemolysis 
PNH sample (9%) Anti-I 1+ 2+ Hemolysis 1+ 
 Pooled AB plasma No hemolysis 
*

Hemagglutination and hemolysis were scored according to Judd et al20 : 0, negative reaction, no agglutination; W, weak reaction, many tiny agglutinates; 1+, very small just visible agglutinates; 2+, many small visible agglutinates; 2+s, medium sized visible agglutinates.

†Presence of hemolysis visualized after incubation with AB serum at 37°C for 60 min.

Close Modal

or Create an Account

Close Modal
Close Modal